19 results
8-K
EX-99.1
MLYS
Mineralys Therapeutics Inc
9 May 24
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:07am
causes of death in the U.S. In 2020, more than 670,000 deaths in the U.S. included hypertension as a primary or contributing cause. Hypertension
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
successor is elected and qualified, or until such director’s earlier death, resignation, disqualification or removal. As detailed below … a termination of service by reason of death or disability and in the event of a change in control (as defined in the 2023 Plan).
Compensation under our non
8-K
EX-99.1
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:43am
are leading causes of death in the U.S. In 2020, more than 670,000 deaths in the U.S. included hypertension as a primary or contributing cause
8-K
EX-99.1
MLYS
Mineralys Therapeutics Inc
22 Dec 23
Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension
9:04am
of death in the U.S. In 2020, more than 670,000 deaths in the U.S. included hypertension as a primary or contributing cause. Hypertension and related
8-K
EX-99.1
m37 q89d4g0
13 Nov 23
Regulation FD Disclosure
8:20am
8-K
EX-99.1
0zg2 eca6nz6t
7 Nov 23
Mineralys Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
n5yntigh9pi vyldqco7
2 Nov 23
Regulation FD Disclosure
10:06am
8-K
EX-99.1
xe6288x05r qw5m3anx
7 Aug 23
Mineralys Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:08pm
8-K
EX-99.1
g263sfxmy4w
15 May 23
Mineralys Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:04pm
DRS/A
gc255
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
ngxq3 mbdi2
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
EX-10.1
p0jg0
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.9
rb3wc7g3m1nej
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.5
rndbcvm9 fl6ei2cr
4 Nov 22
Draft registration statement
12:00am
DRS
d26s836ahs9l1j2e0f
4 Nov 22
Draft registration statement
12:00am
DRS
EX-3.2
bkoju3ur90gi35epy7r2
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.7
ftw9eptde153kwm07a
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.6
gkdzj4 kvx
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next